Update on the merger approval process for the combination of Novozymes and Chr. Hansen: The parties have submitted a remedy proposal to the European Commission.
20 11월 2023 - 4:03PM
Update on the merger approval process for the combination of
Novozymes and Chr. Hansen: The parties have submitted a remedy
proposal to the European Commission.
November 20, 2023
Please see attachment.
Contact information
Investor RelationsAnders Mohr Christensen+45
2515 2364dkamc@chr-hansen.com
Press RelationsSanne Seyer-Hansen+45 6038
6207dksash@chr-hansen.com
- 2023_Update on the merger approval process for the combination
of Novozymes and Chr. Hansen
Chr Hansen (TG:51C)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Chr Hansen (TG:51C)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
